Virtual colonoscopy an alternative to FOB test & colonoscopy for colorectal cancer?

December 30, 2015

Colorectal cancer is the third most diagnosed cancer in the world, with population screening being recommended for early disease detection, however, the most optimal method to screen for the disease remains unknown.

In order to compare different screening methods for colorectal cancer, Lapo Sali, M.D., Ph.D., Department of Biomedical, Experimental and Clinical Sciences 'Mario Serio', University of Florence, and colleagues, in a study published December 30 in the JNCI: Journal of the National Cancer Institute, looked at a data from a single-center randomized controlled screening trial in Florence, Italy, with four parallel groups: biennial fecal immunochemical test (FIT) for three rounds, reduced (r-CTC,) and full cathartic preparation CT colonography (f-CTC,) and optical colonoscopy (OC) in patients aged 54-65 years (16,087 subjects).

The researchers found that participation was different across the four screening methods (50.4% for first-round FIT, 28.1% for r-CTC, 25.2%, for f-CTC, and 14.8% for OC), but detection rates (DRs) of advanced neoplasia were different only between CTC and FIT groups (1.7% for first-round FIT, 5.5% for r-CTC, 4.9% for f-CTC, and 7.2% for OC). They conclude that "The combination of lower attendance and higher DR of screening CTC as compared with FIT are key factors for the optimization of its role in population screening of CRC."

In an accompanying editorial, Ernst J. Kuipers, M.D., Ph.D., and Manon C. W. Spaander, M.D., Ph.D., Department of Gastroenterology and Hepatology, Erasmus University Medical Center, write that the differences in the types of screening for colorectal cancer make it so that there is no test or program design that makes one type of screening better than the other, but feel that follow-up to these types of screenings are essential, and therefore, find that the study is useful to identifying and combatting the disease. "The authors conclude that limitation of the bowel preparation increases the participation in CTC. This is an important new finding that is in line with previous observations that ease is an important determinant of screening uptake."
-end-
Contact Info:

Article: Lapo Sali, M.D., Ph.D., lapo.sali@unifi.it

Editorial: Ernst J. Kuipers, M.D., Ph.D., e.j.kuipers@erasmusmc.nl

Oxford University Press USA

Related Colorectal Cancer Articles from Brightsurf:

Colorectal cancer treatment: the winning combinations
Chemotherapy has distressing side effects for patients and increases the risk of developing resistance to the treatment.

A new model to predict survival in colorectal cancer
This signature could be useful in clinical practice, especially for colorectal cancer diagnosis and therapy.

Roadmap to reducing colorectal cancer deaths
The American Gastroenterological Association has outlined a strategy to increase the number of people screened via tests that are more convenient, accurate and less expensive and tailored to people's individual cancer risks.

Study provides new insight on colorectal cancer growth
A new study by researchers at the University of Kentucky identifies a novel function of the enzyme spermine synthase to facilitate colorectal cancer growth.

Researchers ID target for colorectal cancer immunotherapy
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified a target for colorectal cancer immunotherapy.

Colorectal cancer partner-in-crime identified
A protein that helps colorectal cancer cells spread to other parts of the body could be an effective treatment target.

Cancer cell reversion may offer a new approach to colorectal cancer treatment
A novel approach to reverse the progression of healthy cells to malignant ones may offer a more effective way to eradicate colorectal cancer cells with far fewer side effects, according to a KAIST research team based in South Korea.

A novel pathway to target colorectal cancer
Survival rates for patients with late-stage colorectal cancer are dismal, and new therapeutic strategies are needed to improve outcomes.

Colorectal cancer rates in Canada
The incidence of colorectal cancer among younger adults increased in recent years in this analysis of data from Canadian national cancer registries that included about 688,000 new colorectal cancers diagnosed over more than 40 years.

Cancer drugs promote stem cell properties of colorectal cancer
Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Mannheim University Medical Center have now discovered that a certain group of cancer drugs (MEK Inhibitors) activates the cancer-promoting Wnt signalling pathway in colorectal cancer cells.

Read More: Colorectal Cancer News and Colorectal Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.